Opus Genetics (OPUS) Files Form 144 on April 23, 2023
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowOpus Genetics (OPUS) submitted a Form 144 on April 23, 2023, indicating the intention of insiders to sell shares. This filing can signal possible insider selling, which may impact investor sentiment regarding the stock. The Form 144 provides a legal allowance for selling up to 1% of a company's outstanding shares. Monitoring such filings is crucial for understanding the potential market movements for stocks, especially for smaller companies like Opus Genetics.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News
TSX Stocks Recommended After Carney’s Investing Summit
Oct 26
SoFi Technologies (SOFI) Growth Strong but Rate Sensitivity Dampens Outlook
Oct 26
Shock Lula Win Derails $6 Billion Equity Sales Impacting Banks
Oct 26
Tesla (TSLA) Implied Price Estimated Between $355 and $372 Excluding SpaceX Deal
Oct 26